Trial · NCT00572455
Results by group490
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 490
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.0025% (Stage I) | Baseline | 25.97 | Standard Deviation 2.420 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.005% (Stage I) | Baseline | 26.25 | Standard Deviation 2.400 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.01% (Stage I) | Baseline | 25.90 | Standard Deviation 2.094 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.015% (Stage I) | Baseline | 26.44 | Standard Deviation 1.560 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.02% (Stage I) | Baseline | 28.10 | Standard Deviation 3.102 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.03% (Stage I) | Baseline | 26.26 | Standard Deviation 1.831 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag Vehicle (Stage I) | Baseline | 26.04 | Standard Deviation 2.182 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.0025% (Stage I) | Change at Day 14 | 3.65 | Standard Deviation 1.749 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.005% (Stage I) | Change at Day 14 | 5.40 | Standard Deviation 2.508 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.01% (Stage I) | Change at Day 14 | 7.18 | Standard Deviation 2.749 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.015% (Stage I) | Change at Day 14 | 6.48 | Standard Deviation 4.278 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.02% (Stage I) | Change at Day 14 | 6.00 | Standard Deviation 2.748 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag 0.03% (Stage I) | Change at Day 14 | 6.69 | Standard Deviation 4.563 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 14: Stage I | Taprenepag Vehicle (Stage I) | Change at Day 14 | 0.64 | Standard Deviation 1.382 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 28: Stage II | Latanoprost Vehicle and Taprenepag 0.005% (Stage II) | Baseline | 25.75 | Standard Deviation 2.266 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 28: Stage II | Latanoprost Vehicle and Taprenepag 0.01% (Stage II) | Baseline | 26.47 | Standard Deviation 2.563 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 28: Stage II | Latanoprost Vehicle and Taprenepag 0.015% (Stage II) | Baseline | 26.69 | Standard Deviation 2.509 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 28: Stage II | Latanoprost 0.005% and Taprenepag 0.005% (Stage II) | Baseline | 26.98 | Standard Deviation 2.813 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 28: Stage II | Latanoprost 0.005% and Taprenepag 0.01% (Stage II) | Baseline | 26.36 | Standard Deviation 2.524 | mmHg |
| Change From Baseline in Mean Diurnal Intra Ocular Pressure (IOP) in Study Eye at Day 28: Stage II | Latanoprost 0.005% and Taprenepag 0.015% (Stage II) | Baseline | 27.34 | Standard Deviation 2.876 | mmHg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00572455/results